Akeso marks profit milestone with swift rights issue 康方生物首次年度获利，配股再融资12亿港元
Buoyed by bumper earnings, the biotech has announced a share placement to raise HK$1.17 billion to invest in developing its portfolio of anti-cancer drugs. 康方生物对此次财报表现相当有信心，公布第三日即宣布再次配股融资，筹资所得款项净额将达到11.7亿港元
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.